Catalent, Inc.(CTLT)

Description: Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment provides advanced oral delivery technologies, including formulation, development, and manufacturing of oral dose forms for prescription and consumer health products. This segment's oral dose forms include softgel, modified release technologies, and immediate release solid oral products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. This segment also offers analytical chemical and cell-based testing and scientific services, stability testing, respiratory products formulation and manufacturing, regulatory consulting, and bioanalytical testing for biologic products. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.

---

Keywords: Biotechnology Biopharmaceutical S&P 500 Life Sciences Pharmacy Pharmacology Health Products Inventory Management Ophthalmic Clinical Services Consumer Health Products Delivery Technologies Somerset Respiratory Products Logic Products Biologic Products Specialty Drugs In The United States Inventory Management Services Oral Products Biologic Product Catalent Scientific Services Softgel

---

Home Page: www.catalent.com

CTLT Technical Analysis

14 Schoolhouse Road
Somerset, NJ 08873
United States
Phone: 732 537 6200

---

Officers

Exchange: NYSE

Country: US : United States of America

Currency: US Dollar ($)